WAKIXBeyond's analysis on WAKIX2026-09-16 — Viatris expands pharmaceutical footprint in Japan with approval of WAKIX for narcolepsy and sleep apneaRecent news mentioning WAKIX2026-09-16 — Viatris Announces Approval of WAKIX® (Pitolisant) in Japan, a First-in-Class Treatment for Narcolepsy and Excessive Daytime Sleepiness Associated With Obstructive Sleep Apnea SyndromeAppears alongsideJapanBrowse the full archive →